Hoya’s vision care division acquires Dioptra CZ in Czech Republic
Hoya’s vision care division will acquire 100% of the shares in Dioptra CZ. While the existing management team will remain in place, Rainer Burkard, director of global business
The US Food and Drug Administration (FDA) has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.